Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Aug 14;232(2):359-363.
doi: 10.1093/infdis/jiaf284.

HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV

Affiliations
Observational Study

HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV

Gracie M Rozek et al. J Infect Dis. .

Abstract

Transplantation of kidneys from donors with HIV to recipients with HIV (HIV D+/R+) has been shown to be safe and effective, but there is a unique risk of donor-derived HIV superinfection (HIV-SI) in these recipients. Recipients from a multicenter observational HIV D+/R+ study were examined for HIV-SI by site-directed next-generation sequencing (Illumina). Eighteen recipients of HIV D+/R+ kidney transplants had baseline and follow-up samples that successfully amplified. One recipient was confirmed to have experienced donor-derived HIV-SI at week 26 but did not experience any clinically significant changes. HIV-SI in recipients of HIV D+/R+ transplants is rare, and the clinical ramifications appear negligible.

Keywords: HIV; HOPE Act; kidney; organ transplantation; superinfection.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. Outside the current work, C. M. D. received payment for serving on a grant review committee for Gilead Sciences, and Gilead Sciences donates drug products to 2 studies on which C. M. D. is an investigator. Outside the current work, J. H. reports research support from Pfizer, Janssen, Ferring, Scynexis, AstraZeneca, and the Antibiotic Resistance Leadership Group; a leadership role at the Louisiana Organ Procurement Agency; and payments from Pfizer, AstraZeneca, Innoviva, and the Antibiotic Resistance Leadership Group. D. L. S. received payment as a journal editor for Springer; consulting fees from AstraZeneca, CareDx, Moderna Therapeutics, Medscape, Novavax, Regeneron, Springer Publishing, Hansa, and Roche; and honorarium for AstraZeneca, CareDx, Houston Methodist, Northwell Health, Optum Health Education, Sanofi, WebMd, and ASN. C. A. Q. S. received payment from UpToDate, Inc. J. S. reports research support from F2G, Merck, and Moderna; has received consulting fees from MedCure and OneLegacy; has received honoraria from Viracor/Eurofins; has received support for attending meetings and travel from the International Society for Heart and Lung Transplantation; and serves a leadership role in the American Society for Transplantation Working Group on Older Patients. All other authors report no potential conflicts.

References

    1. Wearne N, Davidson B. HIV-associated kidney disease: the changing spectrum and treatment priorities. Curr Opin Nephrol Hypertens 2024; 33:603–12. - PubMed
    1. Selhorst P, Combrinck CE, Manning K, et al. Longer-term outcomes of HIV-positive-to-HIV-positive renal transplantation. N Engl J Med 2019; 381:1387–9. - PMC - PubMed
    1. Shaffer AA, Durand CM. Solid organ transplantation for HIV-infected individuals. Curr Treat Options Infect Dis 2018; 10:107–20. - PMC - PubMed
    1. Durand CM, Massie A, Florman S, et al. Safety of kidney transplantation from donors with HIV. N Engl J Med 2024; 391:1390–401. - PMC - PubMed
    1. Durand CM, Zhang W, Brown DM, et al. A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant 2021; 21:1754–64. - PMC - PubMed

Publication types